Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
05/2010
05/19/2010EP1330454B1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them
05/19/2010CN101711243A 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054078A1 Gamma secretase modulators
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054064A1 Gamma secretase modulators
05/14/2010WO2010052993A1 Anthracene derivative cycloadded with acylnitroso derivative, and light-activated hno donor
05/14/2010WO2010017093A3 Dopamine receptor ligands with enhanced duration of action
05/14/2010WO2009097515A3 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2742500A1 Gamma secretase modulators
05/14/2010CA2742317A1 Gamma secretase modulators
05/13/2010US20100120855 Macrocylic inhibitors of hepatitis c virus
05/13/2010US20100120839 Pyrazoles useful in the treatment of inflammation
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183256A1 Therapeutic compounds
05/12/2010EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/12/2010CN1938319B Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1713908B Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN101703509A Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
05/12/2010CN101153041B 1,2,3-triazole 1,3-nitrogen heterocyclic compound, producing method and application of the same
05/11/2010US7714118 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration
05/11/2010US7713993 1-(4-fluorophenyl)-3-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}-6,7-dihydro-5H-imidazo-[1,5-a]pyrazin-8-one; for diseases caused by amyloid- beta is Alzheimer's disease, dementia, Down's syndrome or amyloidosis
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/11/2010US7713965 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010US20100113773 Bicyclic oxomorpholine derivative
05/06/2010US20100113504 Amide compounds and their use as antitumor agents
05/06/2010US20100113501 Ophthalmic Composition Comprising Ascomycin
05/06/2010US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds
05/06/2010US20100113446 Hydantoin compounds
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010CA2779261A1 Filamin a binding anti-inflammatory and analgesic
05/06/2010CA2779252A1 Filamin a-binding anti-inflammatory analgesic
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/05/2010EP2182067A2 Hybrid polyketide synthases
05/05/2010EP2181999A1 Method of manufacturing ruboxistarin
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP2181114A1 New drugs with anticholestatic activity
05/04/2010US7709677 e.g.3-{3-[(2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino]phenyl}isonicotinic acid ; useful as agonists at atypical beta-adrenoceptors; treatment of hyperglycaemia, animal growth promoters, blood platelet aggregation inhibitors, as positive inotropic agents and antiatherosclerotic agent
05/04/2010US7709634 Amorphous form of rifaximin and processes for its preparation
05/04/2010US7709497 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
05/04/2010US7709496 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
04/2010
04/29/2010WO2010046517A1 Compounds promoting the activity of mutant glycosidases
04/29/2010WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials
04/29/2010WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
04/29/2010US20100105898 Method for producing scopinium salts
04/29/2010US20100105668 Quinazoline derivatives
04/29/2010US20100105655 Novel compounds 515
04/28/2010EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
04/28/2010EP2178876A1 Spiro condensed barbituric acid derivatives for use as antibacterial
04/28/2010EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators
04/28/2010EP1363640B1 Nucleic acid derivatives
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/22/2010WO2010045251A2 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010WO2010044485A1 Alpha helix mimetics in the treatment of cancer
04/22/2010WO2010043893A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
04/22/2010US20100099915 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
04/22/2010US20100099561 Heterobicyclic alkylthio-bridged isoxazolines
04/22/2010CA2741029A1 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010CA2736335A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
04/21/2010EP2176259A1 Fused imidazoles for cancer treatment
04/20/2010USRE41253 Antineoplastic combinations
04/20/2010US7700773 cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700614 One pot synthesis of tetrazole derivatives of rapamycin
04/20/2010US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides
04/20/2010US7700592 phenylmorpholine and phenylthiomorpholine compounds for treatment of allergic rhinitis, congestion, pain, diarrhea, glaucoma, congestive heart failure, cardiac ischemia, manic disorders, depression, anxiety, migraine, stress-induced urinary incontinence, neuronal damage from ischemia and schizophrenia
04/20/2010US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
04/20/2010CA2565411C Compounds and methods for inhibiting mitotic progression
04/20/2010CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
04/15/2010WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
04/15/2010WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
04/15/2010WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041964A1 Methods for the preparation of alkenylamines, cyclic carbamates or dithiocarbamates, and aminoalcohols or aminothiols
04/15/2010WO2010041726A1 Substituted tricyclic heteroaryl compound
04/15/2010WO2010021680A3 Inhibitors of beta-secretase
04/15/2010US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
04/15/2010US20100093999 Novel fused aminodihydrothiazine derivative
04/15/2010US20100093788 Heterocyclic benzimidazoles as trpm8 modulators
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093779 Hcv ns3 protease inhibitors
04/15/2010US20100093777 Spiro-ring compound
04/15/2010US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/15/2010US20100093716 Therapeutic methods using wrn binding molecules
04/14/2010EP2173756A2 Macrolactone derivatives
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 220